Friday, July 31, 2026

Celltrion’s Truxima becomes first rituximab biosimilar in U.S. to receive interchangeability designation

Celltrion's Truxima gains FDA interchangeability status, enhancing its market position and credibility in blood cancer treatment.

How Samsung Medical Center is Revolutionizing Cancer Patient Care in Asia with EORTC Partnership

Samsung Medical Center's Cancer Hospital partners with EORTC to enhance cancer patients' quality of life through patient-reported outcomes.

Tag: solid fuel

No posts to display

Top News

- Our Sponsors Ad -

Follow us